Loss of LKB1 Leads to Alteration of the Immune Microenvironment in Non-Small Cell Lung Cancer
abstract: The majority of non-small cell lung cancer (NSCLC) patients (70%) are diagnosed with adenocarcinoma versus other histological subtypes. These patients often present with advanced, metastatic disease and frequently relapse after treatment. The tumor suppressor, Liver Kinase B1, is frequent...
| Other Authors: | |
|---|---|
| Format: | Dissertation |
| Language: | English |
| Published: |
2015
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/2286/R.I.29807 |